Trifluoroacetamide

Trifluoroacetamide

SCHEMBL28791510

NC(=O)C(F)(F)F.O=[N+]([O-])c1cc2c(cc1F)CNCC2

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ PNMT P11086 5/20 0.44
▸ ADRA2A P08913 2/20 0.44
▸ ADRA2B P18089 1/20 0.35
▸ ADRA2C P18825 1/20 0.35
▸ MELK Q14680 1/20 0.34
▸ PGR P06401 1/20 0.34
▸ HTR2A P28223 1/20 0.34
▸ HTR2C P28335 1/20 0.34
▸ HTR2B P41595 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13875069 0.88 PNMT (0.54) PNMTADRA2AADRA2BADRA2CPGR
SCHEMBL26601382 0.88 PNMT (0.54) PNMTADRA2AADRA2BADRA2CPGR
Hydrochloric Acid SCHEMBL4169138 0.87 PNMT (0.53) PNMTADRA2AADRA2BADRA2CPGR
SCHEMBL27035058 0.78 ATM (0.46) PNMTADRA2APGR
SCHEMBL20214487 0.76 PNMT (0.50) PNMTADRA2AADRA2BADRA2CHTR2A
SCHEMBL24869958 0.74 PNMT (0.54) PNMTADRA2AADRA2BADRA2CHTR2A
SCHEMBL28069542 0.74 PNMT (0.54) PNMTADRA2AADRA2BADRA2CHTR2A
Trifluoroacetamide SCHEMBL28791521 0.73 MELK (0.53) PNMTADRA2AADRA2BADRA2CMELK
SCHEMBL8258918 0.72 PNMT (0.55) PNMTADRA2AADRA2BADRA2CHTR2A
SCHEMBL18875031 0.71 PNMT (0.54) PNMTADRA2AADRA2BADRA2CHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112142731-B 2, 4-disubstituted pyrimidine derivative and preparation method and application thereof 成都赜灵生物医药科技有限公司 2022-07-22 — — CN disclosed
CN-112142731-A 2, 4-disubstituted pyrimidine derivative and preparation method and application thereof 成都赜灵生物医药科技有限公司 2020-12-29 — — CN disclosed
Send feedback